• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.

作者信息

Liu J C, Peyman G A, Oncel M

机构信息

LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans.

出版信息

Int Ophthalmol. 1990 Jul;14(4):267-70. doi: 10.1007/BF00159862.

DOI:10.1007/BF00159862
PMID:2115030
Abstract

Suprachoroidal hemorrhages were created in 15 albino rabbit eyes by injecting 0.1 cc of autologous blood into the suprachoroidal space. One day later, 10 of these eyes were treated with intravenous tissue plasminogen activator (TPA). Doses of 1 mg per kg were given to each rabbit over 2 to 3 hours by intravenous infusion. Five eyes served as control. The rate of clearance of hemorrhage was compared in the two groups. Average day of clearance was 14 days for the treated group, and 20.2 for the untreated control group. In this study, TPA given intravenously appears to accelerate the clearance of suprachoroidal hemorrhage.

摘要

相似文献

1
Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
Int Ophthalmol. 1990 Jul;14(4):267-70. doi: 10.1007/BF00159862.
2
Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.结膜下注射组织型纤溶酶原激活剂治疗实验性脉络膜上腔出血:一份阴性报告。
Ophthalmic Surg. 1990 Sep;21(9):641-3.
3
Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
Ophthalmologica. 1998;212(2):120-5. doi: 10.1159/000027295.
4
Suprachoroidal hemorrhage: no longer a disaster.脉络膜上腔出血:不再是一场灾难。
Ophthalmic Surg. 1987 May;18(5):329-30.
5
The use of viscoelastic substances in the drainage of postoperative suprachoroidal hemorrhage.粘弹性物质在术后脉络膜上腔出血引流中的应用。
Ophthalmic Surg. 1989 Jul;20(7):504-7.
6
Tissue-type plasminogen activator-assisted drainage of suprachoroidal hemorrhage showing a kissing configuration.
Jpn J Ophthalmol. 2011 Jul;55(4):431-432. doi: 10.1007/s10384-011-0032-4. Epub 2011 Jun 7.
7
The use of viscoelastic substances in the drainage of postoperative suprachoroidal hemorrhage.
Ophthalmic Surg. 1989 Dec;20(12):895.
8
Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.用组织型纤溶酶原激活剂治疗实验性玻璃体出血。
Korean J Ophthalmol. 1990 Jun;4(1):12-5. doi: 10.3341/kjo.1990.4.1.12.
9
Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
Korean J Ophthalmol. 1994 Dec;8(2):45-8. doi: 10.3341/kjo.1994.8.2.45.
10
Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.自旋捕捉剂N-叔丁基苯基亚硝基酮(PBN)和2,2,6,6-四甲基哌啶-N-氧基(TEMPO)在兔血栓栓塞性中风模型中的药理作用:与溶栓组织型纤溶酶原激活剂的联合研究
Stroke. 2001 Jan;32(1):147-53. doi: 10.1161/01.str.32.1.147.

引用本文的文献

1
Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis.重组组织型纤溶酶原激活剂辅助下早期引流累及黄斑的大量脉络膜上腔出血可能导致更好的视觉预后。
Case Rep Ophthalmol. 2025 May 2;16(1):385-394. doi: 10.1159/000545290. eCollection 2025 Jan-Dec.
2
Modified posterior drainage of post-operative suprachoroidal hemorrhage.改良式术后脉络膜上腔出血引流术。
Indian J Ophthalmol. 2021 Dec;69(12):3584-3590. doi: 10.4103/ijo.IJO_3533_20.
3
Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.

本文引用的文献

1
Delayed nonexpulsive suprachoroidal hemorrhage.迟发性非搏动性脉络膜上腔出血
Arch Ophthalmol. 1984 Dec;102(12):1757-60. doi: 10.1001/archopht.1984.01040031421015.
2
Postoperative suprachoroidal hemorrhage following filtration procedures.滤过手术后脉络膜上腔出血
Arch Ophthalmol. 1986 Feb;104(2):201-5. doi: 10.1001/archopht.1986.01050140055019.
3
Suprachoroidal hemorrhage after glaucoma filtering surgery.
Am J Ophthalmol. 1987 May 15;103(5):689-94. doi: 10.1016/s0002-9394(14)74331-4.
重组组织型纤溶酶原激活剂治疗脉络膜上腔出血
Clin Ophthalmol. 2011;5:155-7. doi: 10.2147/OPTH.S16134. Epub 2011 Feb 4.
4
Delayed nonexpulsive suprachoroidal hemorrhage after trabeculectomy.小梁切除术后迟发性非搏动性脉络膜上腔出血
Ophthalmic Surg. 1987 Sep;18(9):661-6.
5
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.心肌梗死溶栓治疗(TIMI)试验——I期:接受重组组织型纤溶酶原激活剂和链激酶治疗患者的出血表现以及血浆纤维蛋白原和纤溶系统的变化
J Am Coll Cardiol. 1988 Jan;11(1):1-11. doi: 10.1016/0735-1097(88)90158-1.
6
Treatment of experimental intravitreal fibrin with tissue plasminogen activator.用组织型纤溶酶原激活剂治疗实验性玻璃体内纤维蛋白。
Am J Ophthalmol. 1987 Dec 15;104(6):619-23. doi: 10.1016/0002-9394(87)90175-9.
7
Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Experimental treatment in a rabbit model.重组人组织型纤溶酶原激活剂的眼内纤维蛋白溶解作用。兔模型中的实验性治疗。
Arch Ophthalmol. 1987 Sep;105(9):1277-80. doi: 10.1001/archopht.1987.01060090135044.
8
New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
Circulation. 1987 Aug;76(2 Pt 2):II31-8.
9
Use of tissue plasminogen activator in experimental hyphema.组织型纤溶酶原激活剂在实验性前房积血中的应用。
Arch Ophthalmol. 1987 Jul;105(7):995-7. doi: 10.1001/archopht.1987.01060070139044.
10
Activation of the fibrinolytic system.纤维蛋白溶解系统的激活。
Cardiol Clin. 1987 Feb;5(1):13-9.